摘要
背景:在研究背景和专门护理中广泛探索使用成像标志物来诊断阿尔茨海默氏病(AD)痴呆前期和早期痴呆阶段。这些标记在初级保健中的使用尚未建立。 目的:总结现有的证据显示,与专门的护理机构相比,AD的成像标记物在初级治疗中的有用性。 方法:文献的选择性综述以及使用基于MRI的海马和基底前脑容积的方法对来自健康对照的AD痴呆和轻度认知障碍(MCI)病例的58例初级保健队列和58例来自记忆门诊样本的匹配病例。 结果:淀粉样蛋白病理学的分子成像标志物和区域性和全脑萎缩的体积标志物支持AD对AD痴呆和MCI的诊断,并有助于在专门护理中鉴别AD和非AD相关痴呆的信心。来自文献和我们的初级保健队列的有限证据表明,体积成像标志物的诊断准确性在AD的痴呆阶段可能相似,但与专门护理相比,MCI初级的病例可能较差。 结论:AD患者早期和鉴别诊断中使用影像学标记物以及初级保健中前驱AD的检测依然缺乏证据。填补这一空白的进一步进展将取决于明确定义的初级保健人群的国际多模式数据的可用性。
关键词: 初级保健,海马体积测定,淀粉样蛋白PET,早期诊断,MCI,临床前阿尔茨海默病。
Current Alzheimer Research
Title:Potential Role of Neuroimaging Markers for Early Diagnosis of Dementia in Primary Care
Volume: 15 Issue: 1
关键词: 初级保健,海马体积测定,淀粉样蛋白PET,早期诊断,MCI,临床前阿尔茨海默病。
摘要: Background: The use of imaging markers for the diagnosis of predementia and early dementia stages of Alzheimer's disease (AD) has widely been explored in research settings and specialized care. The use of these markers in primary care has yet to be established.
Objective: Summarize current evidence for the usefulness of imaging markers for AD in primary compared to specialized care settings.
Method: Selective overview of the literature, and pilot data on the use of MRI-based hippocampus and basal forebrain volumetry for the discrimination of AD dementia and mild cognitive impairment (MCI) cases from healthy controls in 58 cases from a primary care cohort and 58 matched cases from a memory clinic's sample.
Results: Molecular imaging marker of amyloid pathology, and volumetric markers of regional and whole brain atrophy support the diagnosis of AD dementia and MCI due to AD, and contribute to confidence in the differential diagnosis of AD and non-AD related dementias in specialized care. Limited evidence from the literature and our primary care cohort suggests that the diagnostic accuracy of volumetric imaging markers may be similar in the dementia stage of AD, but may be inferior for cases with MCI in primary compared with specialized care.
Conclusion: Evidence is still widely lacking on the use of imaging markers for early and differential diagnosis of AD dementia, and detection of prodromal AD in primary care. Further progress to fill this gap will depend on the availability of international multimodal data from well-defined primary care cohorts.
Export Options
About this article
Cite this article as:
Potential Role of Neuroimaging Markers for Early Diagnosis of Dementia in Primary Care, Current Alzheimer Research 2018; 15 (1) . https://dx.doi.org/10.2174/1567205014666170908093846
DOI https://dx.doi.org/10.2174/1567205014666170908093846 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical Herbal Interactions with Conventional Drugs: From Molecules to Maladies
Current Medicinal Chemistry Comparison of Mono-dopaminergic and Multi-target Pharmacotherapies in Primary Parkinson Syndrome and Assessment Tools to Evaluate Motor and Non-motor Symptoms
Current Drug Therapy Is Amyloid Binding Alcohol Dehydrogenase a Drug Target for Treating Alzheimer’s Disease?
Current Alzheimer Research Analytical Procedures for Secondary Metabolites Determination: Recent Trends and Future Perspectives
Letters in Drug Design & Discovery Is Formaldehyde the Missing Link in AD Pathology? The Differential Aggregation of Amyloid-Beta with APOE Isoforms In Vitro
Current Alzheimer Research Antiangiogenic Therapy and Ovarian Cancer
Current Women`s Health Reviews Maternal Vitamin D Status and Development of Asthma and Allergy in Early Childhood
Mini-Reviews in Medicinal Chemistry Vascular and Parenchymal Mechanisms in Multiple Drug Resistance: a Lesson from Human Epilepsy
Current Drug Targets Insights into Aβ Aggregation: A Molecular Dynamics Perspective
Current Topics in Medicinal Chemistry A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation
Current Pharmaceutical Design Obesity-Induced Cerebral Hypoperfusion Derived from Endothelial Dysfunction: One of the Risk Factors for Alzheimer's Disease
Current Alzheimer Research Preface
Current Drug Targets - CNS & Neurological Disorders Can a Direct IADL Measure Detect Deficits in Persons with MCI?
Current Alzheimer Research Computational Molecular Modeling of Compounds from Amaryllidaceae Family as Potential Acetylcholinesterase Inhibitors
Current Bioactive Compounds Telomere Length Variations in Aging and Age-Related Diseases
Current Aging Science Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease
Current Pharmaceutical Design Preface [Hot Topic: Amyloidogenic Proteins and Peptides Involved in Human Neurodegenerative Diseases (Guest Editor: Brian m. Austen)]
Protein & Peptide Letters Cellular Senescence in Cardiovascular Diseases: Potential Age-Related Mechanisms and Implications for Treatment
Current Pharmaceutical Design Renal Complications of Fabry Disease
Current Pharmaceutical Design The Genetics of Small-Vessel Disease
Current Medicinal Chemistry